What is the evidence for tissue regeneration impairment when using a formulation of PVP-I antiseptic on open wounds?

Dermatology

Volumn 212, Issue SUPPL. 1, 2006, Pages 66-76

  Banwell, Helen ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Povidone iodine; READER scoring tool; Wound healing impairment, evidence based

Indexed keywords

POVIDONE IODINE; TOPICAL ANTIINFECTIVE AGENT;

DRUG EFFECT; EVIDENCE BASED MEDICINE; HUMAN; INJURY; REVIEW; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS, LOCAL; EVIDENCE-BASED MEDICINE; HUMANS; POVIDONE-IODINE; WOUND HEALING; WOUNDS AND INJURIES;

EID: 33745231372     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000089202     Document Type: Conference Paper

References (49)

1. Zamora JL: Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg 1986; 151: 400-406.
2. Iijima S, Kuramochi M: Investigation of irritant skin reaction by 10% povidone-iodine solution after surgery. Dermatology 2002; 204(suppl 1):103-108.
3. Mertz PM, Davis SC, Brewer LD, Franzen L: Can antimicrobials be effective without impairing wound healing? The evaluation of a cadexomer iodine ointment. Wounds 1994; 6: 184-193.
4. Grimmer K: Evidence Based Practice Lecture Notes. Evidence Based Practice Postgraduate Course. Adelaide, University of South Australia, 2002.
5. MacAuley D: READER: An acronym to aid critical reading by general practitioners. Br J Gen Pract 1994; 44: 83-85.
6. Mertz PM, Alvarez OM, Smerbeck RV, Eaglstein WH: A new in vivo model for the evaluation of topical antiseptics on superficial wounds. Arch Dermatol 1984; 120: 58-62.
7. Brennan SS, Leaper DJ: The effect of antiseptics on the healing wound: a study using the rabbit ear chamber. Br J Surg 1985; 72: 780-782.
8. Lineaweaver W, Howard R, Soucy D, McMorris S, Freeman J, Crain C, Robertson J, Rumley T: Topical antimicrobial toxicity. Arch Surg 1985; 120: 267-270.
9. Goldenheim PD: An appraisal of povidone-iodine and wound healing. Postgrad Med J 1993; 69(suppl 3):s97-s105.
10. Kjolseth D, Frank JM, Barker JH, Anderson GL, Rosenthal AI, Acland RD, Schuschke D, Campbell FR, Tobin GR, Weiner LJ: Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. J Am Coll Surg 1994; 179: 305-312.
11. Lawrence JC: A povidone-iodine medicated dressing. J Wound Care 1998; 7: 332-336.
12. Kashyap A, Beezhold D, Wiseman J, Beck WC: Effect of povidone-iodine dermatological ointment on wound healing. Am Surg 1995; 61: 486.
13. Jeng D, Severin JE: Povidone iodine gel alcohol: a 30-second, one time application preoperative skin preparation. Am J Infect Control 1998; 26: 488-494.
14. Mertz PM, Oliveira-Gandia MF, Davis SC: The evaluation of a cadexomer iodine wound dressing on methicillin resistant Staphylococcus aureus (MRSA) in acute wounds. Dermatol Surg 1999; 25: 89-93.
15. Brooks RA, Hollinghurst D, Ribbans WJ, Severn M: Bacterial recolonization during foot surgery: a prospective randomized study of toe preparation techniques. Foot Ankle Int 2001; 22: 347-350.
16. Peter FW, Li-Peuser H, Vogt PM, Muehlberger T, Homann HH, Steinau HU: The effect of wound ointments on tissue microcirculation and leucocyte behaviour. Clin Exp Dermatol 2001; 27: 51-55.
17. Vogt PM, Hauser J, Rossbach O, Bosse B, Fleischer W, Steinau H, Reimer K: Polyvinyl pyrrolidone-iodine liposome hydrogel improves epithelialization by combining moisture and antisepsis. A new concept in wound therapy. Wound Repair Regen 2001; 9: 116-122.
18. Fumal I, Braham C, Paquet P, Pierard-Franchimont C, Pierard GE: The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-ofconcept study. Dermatology 2002; 204(suppl 1):70-74.
19. Koning S, van Suijlekom-Smit LWA, Nouwen JL, Verduim CM, Bernsen RMD, Oranje AP, Thomas S, van der Wouden JC: Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. Br Med J 2002; 324: 1-5 (accessed online: www.bmj.com Oct 4, 2002).
20. Zhou LH, Nahm WK, Badiavas E, Yufit T, Falanga V: Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds. Br J Dermatol 2002; 146: 365-374.
21. Zamora JL: Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg 1986; 151: 400-406.
22. Sharp C, Burr G, Broadbent M, Cummins M, Merriman A: Pressure ulcer prevention and care: a survey of current practice. J Qual Clin Pract 2000; 20: 150-157.
23. Dovison R, Keenan A: Wound healing and infection in nail matrix phenolization wounds. Does topical medication make a difference? J Am Podiatr Med Assoc 2001; 91: 230-233.
24. Dunn JM: Local wound care in the diabetic. Clin Podiatr Med Surg 1987; 4: 413-418.
25. Laufman H: Current use of skin and wound cleansers and antiseptics. Am J Surg 1989; 157: 359-365.
26. Albritton JS: Complications of wound repair. Clin Podiatr Med Surg 1991; 8: 773-785.
27. McDowell S: Are we using too much betadine? Registered Nurse 1991; 54: 43-45.
28. MacLellan DG: Common errors in wound management. Primary Intention 1994; 2: 8-10.
29. Hermans MHE: An overview of physiological aspects of occlusive and non-occlusive dressings. Primary Intention 1995; 3: 8-13.
30. Lawrence JC, Harding KG, Moore DJ: The use of antiseptics in wound care: A critique. J Wound Care 1996; 5: 44-47.
31. Gilchrist B: Should iodine be reconsidered? Nurs Times 1997; 93: 70-76.
32. Gilchrist B: Should iodine be reconsidered in wound management? A report of a consensus meeting on the use of iodine in wound care. J Wound Care 1997; 6: 148-150.
33. McIlwrath M, Johnson M: Antiseptic guidelines for hospital and community settings. Primary Intention 1997; 5: 6-11.
34. Niedner R: Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatology 1997; 195(suppl 2):89-92.
35. Ramstadius B: What is wrong with antiseptics? Aust Nurs J 1997; 5: 19.
36. Burks RI: Povidone-iodine solution in wound treatment. Phys Ther 1998; 78: 212-218.
37. Day MR, Fish SE, Day RD: The use and abuse of wound care materials in the treatment of diabetic ulcerations. Clin Podiatr Med Surg 1998; 15: 139-150.
38. Lawrence JC: The use of iodine as an antiseptic agent. J Wound Care 1998; 7: 421-425.
39. Faoagali J: Use of antiseptics in managing difficult wounds. Primary Intention 1999; 7: 156-160.
40. Gulliver G: Arguments over iodine. Nurs Times 1999; 95: 68-70.
41. Kramer SA: Effect of povidone-iodine on wound healing: a review. J Vasc Nurs 1999; 17: 17-23.
42. Waters M, Fletcher J: Resolving ambiguity and uncertainty. Prof Nurse 2000; 16: 977-981.
43. Fletcher J, Gilchrist B: Should antiseptics ever be used to manage wounds? Nurs Times 2000; 96: 18.
44. Pray WS: Minor wound care for diabetic patients. US Pharm 2001; 26 (accessed online October 3, 2002).
45. Jones V, Milton T: When and how to use iodine dressings. Nurs Times 2000; 96: 2-3.
46. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJM: A comparison of two diabetic foot ulcer classification systems. Diabetes Care 2001; 24: 84-88.
47. Han P, Ezquerro R: Diabetic foot wound care algorithms. J Am Podiatr Med Assoc 2002; 92: 336-349.
48. Rikimaru T, Kondo M, Kondo S, Oizumi K: Bacterial activities of povidone-iodine against mycobacterium. Dermatology 1997; 195(suppl 2):104-106.
49. Kawana R, Kitamura T, Nakogomi O, Matsumoto I, Arita M, Yoshihara N, Yanagi K, Yamada A, Morita O, Yoshida Y, Furuya Y, Chiba S: Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology 1997; 195:(suppl 2):29-35.